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In this work, 6-phosphogluconic trisodium salt (6-PG-Na+) is introduced as a new aqueous and 
non-toxic crosslinking agent to obtain ionic hydrogels. Here, it is shown the formation of 
hydrogels based on chitosan crosslinked with 6-PG-Na+. This formulation is obtained by ionic 
interaction of cationic groups of polymer with anionic groups of the crosslinker. These 
hydrogels are non-toxic, do not cause dermal irritation, are easy to extend and have an 
adequate adhesion force to be applied as polymeric film over the skin. This formulation 
exhibits a first order release kinetic and can be applied as drug vehicle for topical 
administration or as wound dressing for wound healing. The primary goal of this 
communication is to report the identification and utility of 6-phosphogluconic trisodium salt 
(6-PG-Na+) as a non-toxic crosslinker applicable for cationic polymers. 
Keywords: 6-phosphogluconic trisodium salt, ionic hydrogel, chitosan, wound healing, drug 
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The skin is the most extensive organ of the body, it supposes 10-15% of the corporal weight, 
and it fulfills diverse physiological functions.  A multitude of pharmaceutical forms of 
cutaneous application have been developed for different objectives: topical treatment of skin 
diseases or cosmetic application, transdermal administration of drugs for systemic treatment, 
etc. 
Hydrogels have a special place in this field as they can act as local or transdermal drug delivery 
systems 1-4 such as patch´s matrices 5 for containing and controlling the release of the active 
ingredients and for forming compatible, adhesive and flexible polymer films on the skin with a 
variety of potential applications 6.  
Another area of research in this field is the development of hydrogels applied to wound 
healing. There are many published works 7-12 on this topic and products marketed 13-15. Also, 
multiple patents have contributed to increase this field of knowledge 16-18.  
Due to the importance of these polymeric systems, the search for new molecules with 
crosslinking capacity allows the development of new formulations with different 
physicochemical characteristics that may lead to advances in various pharmaceutical 
applications. 
In this work the 6-phosphogluconic acid trisodium salt (6-PG-Na+) has been investigated as a 
ionic crosslinking agent for cationic polymers (Fig. 1).  
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6-Phosphogluconic acid (6-PG) is a metabolite of the pentose phosphate pathway, in which 
glucose is degraded into pentose-phosphate for nucleic acid biosynthesis and into NADPH to 
obtain energy for said process. Degradation of glucose through this route is necessary in some 
specific tissues (adipose tissue, adrenal cortex, liver, etc.) in which the biosynthetic reactions 
are elevated 19. 
In the early 70s a patent was issued in which it was demonstrated that 6-phosphogluconic acid 
(6-PG) and its salts can be used as regenerating agents of liver tissue. In this study, the liver of 
albino rats, previously excised, was regenerated after 2-8 days of intraperitoneal treatment 
with 150 mg/kg·day of 6-PG-Na+ 20. 
To date, neither 6-PG nor its salts have been described as crosslinking agents. However, the 
literature describes several examples of molecules with phosphate groups capable of forming 
hydrogels by ionic crosslinking, such as β-glycerol phosphate 21, tripolyphosphate 22, 
pyrophosphate 23, glucose 1-phosphate 24, and ammonium hydrogen phosphate 25.  
For all the above, this work aims to develop a modified drug delivery system based on a 
cationic polymer, chitosan, cross-linked with an anionic molecule, 6-phosphogluconic acid (6-
PG-Na+) trisodium salt and to explore its applications as system for topical administration. 
 
2. EXPERIMENTAL SECTION 
2.1 Materials 
The materials used in this research were: chitosan (deacetylation degree = 81%, MW = 190-310 
kDa), piroxicam, 6-phosphogluconic acid trisodium salt (6-PG-Na+), dimethylsulfoxide (DMSO), 
KH2PO4, NaCl, HCl 35%, NaH2PO4 and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazole (MTT) 
bromide were purchased from Sigma Aldrich.  
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2.2 Hydrogel formation 
In a standard preparation, to 0.77 g of chitosan 2% in HCl 0.1 N (0.05 mmol of chitosan 
repetitive units) were added different volumes of a stock solution of 6-PG-Na+ in water (100 
mg/ml), which molar amounts were 0.02, 0.05, 0.10, 0.13 mmol, to achieve a crosslinking 
percentages (mol of 6-PG-Na+/mol of chitosan repetitive units) of 50%, 100%, 200%, 275%, 
respectively. This mixture was stirred for one minute until a homogeneous and whitish 
dispersion was obtained. After the stirring the gel formation was considered concluded 
because the gelation process is very fast. 
Samples of the formulations were lyophilized for preservation. The product obtained can be 
easily ground and rehydrated in aqueous medium in the moment it has to be used. Swelling, 
release and wound healing tests were done on a disk shape dry sample (lyophilized hydrogel), 
the other tests shown were performed on re-hydrated samples 26. 
2.3. Drug loading method 
The loading of piroxicam, used as a model drug, was performed simultaneously to the 
formation of the hydrogel. A film of 2.5 mg of piroxicam was prepared by evaporating an 
adequate volume of stock solution of drug in acetone overnight. Then, 0.77 g of the polymer 
solution was added to the vial containing the drug and allowed to stir for about two hours until 
the drug was detached and dispersed among the polymer. The crosslinking agent was then 
added and stirred for one minute until the formation of the hydrogel. 
Using this methodology, chitosan hydrogels were obtained with different percentages of 
crosslinking. Table 1 summarizes the nomenclatures used to name each of the formulations: 
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Hydrogels Hydrogels with piroxicam 
50% M60-50 M6P-50 
100% M60-100 M6P-100 
200% M60-200 M6P-200 
275% M60-275 M6P-275 
Table 1. Scheme of hydrogels studied based on their percentage of crosslinking and presence or 
absence of drug. 
2.4. Swelling  
Dynamic swelling analysis was performed on lyophilized samples of M60-100 and M60-275, 
which had a disc shape. They were introduced into metal baskets, which allow the entry of 
fluid but avoid the exit of the formulation, in order to avoid that the possible disintegration of 
the system would hamper hydrogel weighing. The baskets were introduced into vessels with 
different media buffered at pH 1.2, 4.5, 6.8 and 7.5 for 48 hours at 37°C. At predetermined 
time intervals, the baskets were extracted from the medium, their surface was carefully dried 
with filter paper and weighed, finally being returned to the same medium. Before the 
beginning of the experiment, baskets and hydrogel samples were weighed individually on a 
balance (Acculab, Sartorious Group, Atilon, max 220 g, d = 0.1 mg). Each condition of pH and 
degree of crosslinking was studied in triplicate. 
The weight of the hydrogels samples at each time was calculated by difference between the 
total weight and the weight of the basket used to keep the sample in. The swelling degree 
normalized at time t (Qt) was calculated in terms of weight of water per weight of dry hydrogel 
using equation 1. 
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  =	 −	  (1) 
Where m0 is the initial weight of the dry hydrogel (xerogel) and mt is the weight of the 
hydrogel at time t.  
2.5 Release profiles 
The test was carried out in vessels placed on a thermoregulated orbital incubator (Stuart 
orbital incubator SI50) at 37°C and 100 oscillating motions per minute for 48 hours. The 
hydrogels M6P-100 and M6P-275 were introduced into metal baskets, which allow the entry 
and exit of dissolved drug and fluid but avoid the exit of the hydrogel. Baskets were introduced 
into vessels with different media buffered at pH 1.2, 4.5, 6.8 and 7.5 for 48 hours at 37 ° C. 
Sampling was performed at predefined times and the removed volume was refilled with the 
corresponding medium. Amount of piroxicam in the samples was determined by HPLC as 
mentioned below. The experiment was performed in triplicate for each pH value and percent 
of cross-linking. The release profiles obtained were compared by the similarity factor, f2, using 
equation 2.  
 	 = 	50 ·  1 + 1 ·( − 

 )	
. · 100! (2) 
Where n is the number of pairs of points compared, Rt is the release percentage for the 
reference formulation at each time and Tt is the percentage of release in the tested 
formulation at each time. 
The adjustment of the profiles to establish the kinetic release model was performed by 
applying Korsmeyer-Peppas equation (equation 3). Experimental values were used up to a 
release percentage of 60% of the total amount present in the hydrogel. 
To better characterize the release process, we also used the study of the first order model 
(equation 4) and Peppas-Sahlin model 27 (equation 5): 
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Where k1 is the first order kinetic constant and Mt is the amount of drug released at time t. 
 
""& = '()* +	'+)	* (5) 
Where the term kDt
m corresponds to the contribution of the Fickian diffusion mechanism (kD is 
the diffusional constant), and the term kRt
2m, to the Case II transport mechanism (kR is the 
relaxation/erosion constant). The coefficient m is the purely Fickian diffusion exponent for a 
matrix of any geometric form that has controlled release. The adjustment of the kinetic models 
and the calculation of the parameters was done using Solver to minimize the Residual Sum of 
Squares (RSS) between experimental and theoretical concentrations. 
Quantification method 
Determination of piroxicam was carried out at 30°C on a Waters stainless steel column model 
Nova Pak C-18 150mm length, 3.9 mm in diameter and particle size of 4μm preceded by a 
Phenomenex® KJ0-4282 precolumn (Phenomenex AJO-4287, C18 4 x 3.0 mm). The solvent 
delivery system (Alliance System (Waters 2695)) was used to deliver a mobile phase 50:50 
trifluoroacetic acid aqueous solution at pH 3 and acetonitrile. The flow rate was 1 mL/min. 
Detection was performed using a Waters® 2487 double λ absorbance detector with a 
wavelength of 356 nm.  
2.6. Toxicity  
The ability of the hydrogels to interfere with the growth of Caco-2 cells was determined in vitro 
using the 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay based on 
the metabolic reduction reaction in mitochondria of the yellow-colored compound 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazole (MTT) into the blue-colored formazan. The 
formation of the blue compound can be followed spectrofotometrically at 490 nm and the 
absorbance value is proportional to the number of living cells. 
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Assays were carried out in 96-well microliter plates with flat-bottomed wells at a density of 
25000 cells per well. Cultures were grown at standard conditions. 24 h later, the medium was 
replaced with a fresh medium and 50 μL of the dispersed gel samples, 6-PG-Na+ and chitosan (5 
mg/mL in PBS) were added. Plates were incubated for 24, 48, or 72 h and then, 20 μL of MTT 
solution (5 mg/mL) were added to each well. The samples were incubated at 37°C for 3 h to 
allow reaction for the formazan formation. The content of each well was removed and the dark 
blue crystals were redissolved in DMSO. Absorbance was measured at 490 nm with a 
Labsystems Multiskan EX plate reader. Assays were carried out in quadruplicate for each 
treatment. Data were expressed as a percentage of the absorbance of the untreated control.  
Differences between cellular survival values were studied by the ANOVA statistical test with a 
level of significance p = 0.05. 
2.7. Rheological characterization 
Rheological characterization was performed using a controlled stress rheometer, RheoStress 
RS 1 (Thermo Haake, Germany) equipped with control and data logging software (RheoWin 
4.0.1) and a Haake K10 thermostat bath. After loading the samples, they were kept at rest for 
at 600 seconds in order to assure sample relaxation and temperature equilibrium. To avoid 
drying during measurement the free edges of the sample were covered with silicone oil 
(Dimethicone RFE/Ph. Eur.). All measurements were performed in triplicate at 25 oC using a 
titanium cone-plate sensor (35 mm, 2 degree).  
Flow curves, viscosity as a function of shear rate, η = f ( γ& ), were performed both in control 
stress mode and control rate mode. In order to obtain zero shear viscosity, η0, stepped flow 
curves in controlled stress mode were carried out (30 s each step in logarithmic stress values 
distribution). Shear stress range was chosen in order to obtain viscosities for shear rates 
ranging from 0.001 to 100 s-1 approximately. This interval was chosen in order to avoid 
centrifugation of the sample occurring at higher shear rates. Due to the abrupt viscosity drop, 
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the flow curve was complemented with a step flow curve in control rate mode (10 s each step 
in logarithmic distribution). 
Small amplitude oscillatory sweeps (SAOS) were carried out in order to analyse viscoelastic 
behaviour of the gel. The linear viscoelastic region (LVR) was previously determined by a stress 
sweep performed at 1 Hz. A stress amplitude of 5 Pa, within the LVR was chosen for SAOS.  
Both, storage modulus (elastic modulus), G’, and loss modulus (viscous modulus), G”, at 
different frequencies from 0.01 to 10 Hz in logarithmic distribution (9 points per decade), were 
obtained.  
2.8. Extensibility  
The extensibility test was carried out according to the standard procedure PN/L/CP/003/00 of 
extensibility determination in the second edition of the Spanish National Formulary (Order 
SSI/23/2015). 
In this case, 0.5 g of sample was deposited between two glass plates and it was compressed by 
applying increasing weights for 30 seconds. After each time interval the area of extension was 
calculated with the aid of a millimeter paper located below the bottom plate. 
The assays were performed in quadruplicate for the rehydrated M60-275 hydrogel (120 mg dry 
hydrogel/ml water, equivalent to 30 mg chitosan/ml water). In order to compare, commercial 
carbomer gel (Salvacam®) and rehydrated chitosan were also tested. The latter formulation 
was prepared by lyophilizing chitosan 2% in 0.1 N HCl and adding water to obtain the same 
polymer concentration as that of the hydrogel, i.e., 30 mg / ml. 
2.9. Adhesion to the skin 
Patch adhesion to the skin was measured in terms of force required to peel it off the skin, using 
a modification of the Loop Tack test 28. 
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This measurement was carried out in a dynamometer constituted by a lower support in which 
the skin is placed and an upper device with a clamp function that is able to elevate registering 
the force exerted for that purpose. Pig ear skin was firmly attached to plates which were placed 
on the bottom of the dynamometer. 0.4 g of the rehydrated hydrogel (120 mg dry hydrogel/ml 
water) were spread over the skin forming a film of 1 mm of thickness and 1.9 × 4.5 cm of area. 
The hydrogel was allowed to dry for 30 minutes and an adhesive tape of 1.9 x 4.5 cm was 
attached to it. The ends of the tape were fastened to the top of the instrument by a clamp-type 
grip. Measurement of patch adhesiveness to the skin was performed by raising said top device 
at a speed of 500 mm/s and recording the maximum force taken to peel it off. Five 
measurements were made for the M60-275 hydrogel. 
2.10. Dermal irritation  
Acute dermal irritation was assessed according to the procedure described in OECD guide 404 
29. The protocol was approved by the Ethics Committee (2016/VSC/PEA/00137). The test was 
realized as follows: First, the dorsal area of the animal is shaved avoiding to cause abrasion. 24 
hours later, 0.3 grams of rehydrated hydrogel (120 mg dry formulation/ml water) is applied 
over an area of 6 cm2. The patch is left for 15 minutes, then it is removed and the skin is 
observed. If there are no signs of irritation, the formulation is applied again on another skin 
area and left for 1 hour. In case of no irritant effects when removing the hydrogel, the 
procedure is repeated allowing the patch to contact with skin for 4 hours. When removing each 
patch, the area has to be washed with moistened gauze to eliminate any traces of the 
formulation. If skin irritation is not observed after removal of the formulation at 4 h, the animal 
is observed for 14 days. This is a sequential test, so this procedure is done first in a rabbit; a 
second rabbit serves as a confirmatory test if in the initial test the formulation has been 
observed to be non-irritant. The procedure in the second animal is the same, removing the 
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formulation at 15 minutes, 1 hour and 4 hours. If the result in the two rabbits is the same it is 
not necessary to test a third one; otherwise, a third animal is tested with the same procedure. 
During the trial, images of treated areas and control area (healthy skin) were taken at different 
times to assess the presence of signs of irritation. The assay was performed on two rabbits. 
2.11. Franz cell permeability  
Skin permeation studies were performed using excised porcine ear skin on diffusion cells called 
Franz cells. Excised porcine ear skin was equilibrated for 30 min in 0.9% NaCl before being 
mounted in vertical Franz-type diffusion cells (area of 2 cm2). The receptor compartment (10 
mL) was filled with PBS (pH 7.4). The receptor fluid was stirred at a constant speed of 100 rpm. 
Temperature was adjusted to 32 ± 0.1 °C using a circulating water bath. Rehydrated hydrogel 
(0.5 g, containing 2.5 mg piroxicam) was applied on the donor compartment. Aliquots of the 
receptor fluid were withdrawn at different time points (14, 16, 18, 20, 22 and 24 h) and were 
immediately replaced with an equal volume of fresh PBS. The drug concentration in each 
sample was quantified using the HPLC method mentioned above in order to calculate the flux 
of piroxicam across the skin. 
At the end of the transdermal permeation experiments (24 h), skin samples were immersed in 
methanol for 24 h under constant stirring in order to extract the drug. The hydrogel residues 
obtained from the donor compartment were treated with 35% HCl, sonication and methanol 
to dissolve the remaining piroxicam therein. Subsequently, they were neutralized with the 
addition of a diluted NaOH solution. Samples were filtered and analysed using the validated 
HPLC method to determine the amount of piroxicam retained in the skin. 
The rehydrated M6P-275 hydrogel (120 mg dry preparation/ml solution) was studied in two 
different media: formulation 1 (10% propylene glycol) and formulation 2 (10% glycerol, 10% 
isopropyl alcohol and 10% propylene glycol). 
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Assays were performed septuplicate (n=7) for each tested formulation. The results were 
evaluated using the t-student statistical test for independent samples with a 95% confidence 
interval. 
2.12. Wound healing 
The aim of this section was to determine the healing capacity of the chitosan hydrogels based 
on 6-PG-Na+ by evaluating the healing rate of full thickness wounds. 
The in vivo animal study was approved by the Ethics Committee on Experimental Research 
(protocol UMH-DI-MBS-03-14), at Miguel Hernandez University, Spain. Female Wistar rats, 
weighing 250−290 g and 4−6 weeks of age, were used in this study. The rats were divided into 
four groups and each group contained four rats (n = 4); the rats of group 1 were treated with 
chitosan dressing, those of group 2 with 0.25 ml of 6-PG-Na + 180 mg / ml solution in water, 
group 3 with the hydrogel M60-275 and those of group 4 were not treated. The chitosan 
dressing consisted in 0.77 g of 2% polymer; dressings for group 3 contained 0.77 g of 2% 
polymer crosslinked with 275% 6-PG-Na+, both prepared as disk shaped lyophilized samples. 
Animals were allowed to take normal rat feed and water without restriction. 
On the day of wounding, the rats were anaesthetized by intraperitoneal injection of 40.0 
mg/kg pentobarbital and were also injected subcutaneous buprenorphine 0.3 mg/kg as 
analgesic. The dorsal area of the rats was depilated and the operative area of skin cleaned with 
alcohol. A full thickness skin wound of 3 cm diameter was prepared by excising with surgical 
scissors; the dorsum of the rat was photographed and covered with the corresponding 
formulation studied, a non-stick gauze and a plaster. In the case of the untreated group, the 
wound was covered only with the nonstick gauze and the plaster. After applying the dressing 
materials, the rats were housed individually in cages under normal room temperature. During 
the two weeks following the surgical creation of the wound, 1 g/L acetaminophen was 
administered in water. 
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The dressing materials were changed at days 7, 14 and 21 after skin excision. During the 
changing of dressings, photographs were taken at the wound area. After day 21, animals were 
sacrificed by intravenous injection of sodium pentobarbital 90 mg/kg and the skin wound 
tissue was excised, fixed with 4% formalin, processed and paraffin embedded. The cross-
sections prepared were stained with hematoxylin−eosin (H&E) reagent for histological 
observations. These histological samples were observed using a vertical optical microscope 
(Leica model DMR) recording the digital images with a camera (Leica model DFC450C) to study 
the state of the skin in the different treatment groups. 
Photographs taken at days 0, 7, 14 and 21 were analyzed with ImageJ® software to quantify the 
wound area and to calculate the healing rate in different groups. The percentage of wound 
closure for each time was determined by equation 6: 
 %	-./	01.2# = 3 − 33 · 100 (6) 
Where A0 is the initial wound area and At is the wound area at time t. 
The differences between the percentages of wound closure were studied using the statistical 
ANOVA test of a factor with a significance level p = 0.05. A parametric or non-parametric post 
hoc test was selected based on the homogeneity of the variances determined by the Levene 
test. 
 
3. RESULTS AND DISCUSSION  





The hydrogel is prepared by the ionic interaction between the positive charges of the amino 
groups of the polymer and the anions of the 6-PG-Na+. The mechanism of formation is based 
on the fact that chitosan is a weak basic polymer (pKa 6.5) and therefore, at acidic pH chitosan 
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is ionized. In this same sense, the pKa of the phosphoric group of 6-PG are 1.5 and 6.6, and the 
pKa of the acid group is 3.4, so at neutral pH the molecule is ionized (Fig 2).  
 





The swelling study reveals the ionic character of the polymer network, since at pH≤4.5 the 
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Fig.3. Swelling profiles of samples M60-100 and M60-275 in buffered aqueous medium at: a) 
pH 1.2, b) pH 6.8, c) pH 4.5 and d) pH 7.5 
On the other hand, at pH values close to neutrality, that is, pH 6.8 and 7.5, an overshooting 
effect is observed, that is, the swelling curves show a maximum following with a gradual 
decrease until the swelling equilibrium. The difference in the results obtained as a function of 
pH is due to the different degree of ionization of the functional groups that form part of the 
crosslinking ionic bond. When the hydrogel is in a relatively neutral pH medium, the 6-PG-Na+ 
molecules have a greater number of negative charges, which favors a greater number of 
crosslinking interactions. However, at acidic pH 6-PG-Na+ does not have sufficient negative 
charges to maintain polymer cross-linking.  
It is also observed that the swelling value is 1.5 to 2.5 times greater for the less crosslinked 
hydrogel. Therefore, it is concluded that the higher percentage of crosslinking, the lower the 
swelling is, because the crosslinks between the polymer chains limit the relaxation and 
expansion of the matrix. 
3.3. Release profiles 
The release profiles are plotted to compare the influence of pH the percentage of cross-linking 
(Fig. 4) on drug release. Values of the similarity factor for each of these comparisons are shown 
in table 2.  
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Fig. 4. Piroxicam release profiles as a function of the pH medium for the sample: a) M6P-100 
and b) M6P-275 
  
pH 1.2 pH 4.5 pH 6.8 pH 7.5 
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Table 2. Values of f2 for the comparisons of profiles as a function of pH and degree of 
crosslinking 
Based on the f2 values it is concluded that there are significant differences between the 
release from hydrogels with different degree of crosslinking at any pH. Also, differences 
between the release profiles of the same hydrogel at different pH values were observed, 
except for M6P-100 at pH 4.5-6.8, and at pH 6.8-7.5, and for M6P-275 at pH 6.8-7.5. 
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Korsmeyer-Peppas equation was applied to determine values of the diffusional exponent (n) 
and the kinetic constant (K) (table 3). In general, the diffusional exponent value is between 0.5 
and 1, which is consistent with a release influenced by both the diffusion and the relaxation of 
the polymer chains, called "anomalous transport". Results obtained with Korsmeyer-Peppas 
suggested the study of other kinetic models, as order one and Peppas-Sahlin to better 
characterize the release. First order is the kinetic release model that best fits the experimental 
data, as shown in table 3, which collects the RSS values of these models. This kinetics is 
representative of the pharmaceutical forms which combined release by Fick diffusion and 
relaxation/erosion of the polymer matrix, which is in agreement with the experimental 
observations of matrix disintegration at acidic pH (pH 1.2-4.5). The higher the pH of the 
medium and higher the crosslinking percentage, the smaller the order one constant values, 
and, therefore, the slower and longer the release is.  
  




) RSS k1 (h
-1
) RSS RSS 
M6P-100 
pH 1.2 0.71 1.34 5.08·10-12 3.04 2.53·10-3 1.71·10-2 
pH 4.5 0.73 0.80 1.40·10-3 1.47 3.91·10-3 9.67·10-2 
pH 6.8 0.87 0.74 1.40·10-3 1.20 6.23·10-3 1.57·10-1 
pH 7.5 0.95 0.64 6.10·10-5 0.98 7.67·10-3 4.08·10-1 
M6P-275 
pH 1.2 1.39 0.62 5.79·10-4 1.06 1.04·10-1 2.05·10-1 
pH 4.5 0.73 0.53 2.01·10-3 0.85 8.31·10-3 6.00·10-2 
pH 6.8 0.67 0.36 2.98·10-3 0.48 6.24·10-3 4.45·10-2 
pH 7.5 0.57 0.37 7.67·10-3 0.39 2.46·10-2 2.18·10-1 
Table 3.RSS values of model fit: Korsmeyer-Peppas, first order and Peppas-Sahlin, and model 
parameters: Korsmeyer-Peppas (n y k) and first order (k1)  
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Our results concerning swelling and drug release agree with those found by other authors 30, 31 
that is, as polymer crosslinking increases swelling and drug release decrease. These facts that 
can be attributed to increased microstructural tortuosity and decreased space between 
macromolecular chains, as porosity is reduced water entrance is reduced and release slowed. 
3.4. Caco-2 toxicity 
Despite chitosan are widely described as non toxic and biocompatible molecule 26 it is 
necessary to perform toxicity assays of the hydrogels in order to verify the toxicity after the 
gelation process with the linker molecule.  There are no statistically significant differences in 
percentage of cell survival between the different groups, so it is concluded that both the 
starting components (polymer and crosslinking agent) and the hydrogels lack of toxicity (Fig. 
5). 
 





, chitosan M60-100 and M60-275 
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It is well known that chitosan forms aqueous solutions with a flow behaviour that is almost 
Newtonian, not dependent on shear rate, and a fluid-like viscoelastic behaviour 32, 33. 
Therefore, this polymer needs a crosslinking agent in order to form rheological gels 34, 35.  
The gels studied have a strong shear thinning behaviour, since the viscosity decreases more 
than four order of magnitude when increasing shear rate. A representative flow curve is shown 












Where the zero shear viscosity, η0 corresponds to the plateau of constant viscosity observed 
for very low shear rates, 
c
γ& , is related to shear rate at which viscosity begins to drop and s is 
the shear thinning index, what indicates the slope of the viscosity drop in the log-log plot. The 
mean values obtained for the three replicates are η0 = 54000  ± 15000 Pa, cγ&  = 0.0028  ± 
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Fig. 6. Representative flow curve for the hydrogels studied. Values of viscosity obtained when 
applying different shear stresses and different shear rates.  
The high value of zero shear viscosity is in agreement with the semisolid consistency of a 
hydrogel. On the other hand, due to the high shear thinning character the viscosity for rubbing 
velocities is only 1 Pa s, which implies it is easy extensible, as shown in next section. The 
hydrogel remained homogeneous within the shear rate range used, prior to centrifugation of 
the sample. 
From oscillatory measurements, the viscoelastic moduli for different oscillation frequencies 
were obtained. The mean values are plotted in Figure 7. The elastic behaviour dominates the 
viscous one, as G’ > G” 32, 33. This is typical of gel-like consistency and indicates the existence of 
an internal three-dimensional network, what confirms the action of the crosslinking agent on 






















Frequency (Hz)  
Fig. 7. Mean values and standard errors of the viscoelastic moduli as a function of the 
frequency of the oscillation performed (stress amplitude= 1 Pa, in LVR). Closed symbols: G’, 
Open symbols: viscous modulus, G”. 
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Obtaining optimum rheological properties facilitates the extension of the formulation on the 
epithelial surface creating a film which allows the uniform release of the drug, ensuring the 
efficacy of the preparation. The extensibility of the hydrogels M60-100 and M60-275 have 
been compared to the uncrosslinked polymer at the same concentration and with a 
commercial formulation of carbomer gel (Salvacam®) (Fig. 8). 
 
Fig. 8. Values of the extension area of commercial gel, chitosan and hydrogels M60-100 and 
M60-275 as a function of the applied weight 
The fact that the extensibility of the hydrogel formulations is lower than that of chitosan 
dispersion confirms again the action of the crosslinking agent on the chitosan. As mentioned 
above, chitosan shows a fluid-like viscoelastic behaviour, and accordingly as expected, it 
showed high values in the extensibility assay. The hydrogel formulations evaluated have an 
extensibility similar to that of the commercial gel and are considered suitable for topical 
application. This property reinforce the good characteristics of the formulation prepared, 
when re-hydrated, the semisolid consistency of the formulation allows its spreading on skin 
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3.6. Adhesion to the skin 
The rehydrated hydrogel is a semi-solid formulation with a uniform viscous consistency. After 
application to the skin, in the form of a thin layer of product, the polymer network dries, so 
that at 20-30 minutes a transparent film is formed which adheres to the skin, adapting to its 
shape and with a certain elasticity that allows normal movements. The adhesion to the skin of 
this polymer film was analyzed by the Loop Tack test, obtaining an adhesion force of 3.17 ± 
0.57 Newton. 
There is no standard method for performing this measurement. The disadvantage of adhesives 
is that their removal causes pain, which is greater the greater the adhesive force is. The 
formulation proposed in this work has adequate adhesiveness to the skin and does not detach 
when is lightly moistened. However, it can be easily removed from the skin by rehydrating it 
for a few minutes with a cotton or gauze soaked in water and subsequently with a slight 
friction without causing pain. 
3.7. Dermal irritation 
The study of dermal irritation has been performed in rabbits due to the skin of these animals is 
more sensitive than the human skin; further it is assumed that the compounds which cause 
corrosion or irritation are similar in humans and in rabbits. The reason for prolonging the 
exposure until 4 hours is to check if the sensitivity of the skin to the compound increases, so 
that if it causes irritation is easier to detect. This test may be over-predictive, ie it is a 
conservative test for irritation/corrosion in humans. 
The study was carried out in two rabbits since, according to OECD TG 404, the reduction of 3 to 
2 animals tested had no impact on the classification and in the two animals tested the same 
results were obtained. The rehydrated hydrogel has demonstrated to be non-irritating. 
3.8. Permeability 
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The evaluation of hydrogels as modified drug delivery systems in skin has been performed by 
determining the amount of drug present in skin and receptor and the permeability constant 
(Kp). The rehydrated M6P-275 hydrogel has been evaluated in two media of different 
composition. In formulation 1, the medium is composed of 10% propylene glycol; in 
formulation 2, the medium is composed of 10% propylene glycol, 10% glycerol and 10% 
isopropyl alcohol. Table 4 shows the values of permeate per cm2, the permeability constant 















14 8.34·10-4 ± 9.40·10-5 9.98·10-5 ± 3.33·10-5 
16 9.10·10-4 ± 1.11·10-4 1.73·10-4 ± 9.60·10-5 
18 1.04·10-3 ± 1.11·10-4 2.06·10-4 ± 1.32·10-4 
20 1.15·10-3 ± 1.51·10-4 2.20·10-4 ± 1.08·10-4 
22 1.26·10-3 ± 1.95·10-4 2.82·10-4 ± 1.22·10-4 
24 1.37·10-3 ± 1.73·10-4 2.98·10-4 ± 1.21·10-4 
Kp (cm/s) 1.11·10-5 ± 2.51·10-6 3.97·10-6 ± 2.23·10-6 




1.31·10-2 ± 8.72·10-3 3.20·10-2 ± 9.89·10-3 
Table 4. Amount of drug permeated at each time, permeability constant and amount of drug in 
skin at 24 hours for formulations 1 and 2 
 
The permeability constant of formulation 1 is significantly higher than that of formulation 2, so 
the amount reaching the receptor is higher. In contrast, the amount of drug retained on skin at 
24 hours is significantly greater for formulation 2. 
Based on the results obtained it is concluded that the hydrogel M60-275 allows the 
administration of drugs at the topical level, without being absorbed significantly. The 
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permeability of the drug in the skin can be regulated by modifying the rehydration medium of 
the hydrogel. This polymer system could serve as a vehicle for the topical treatment of 
cutaneous diseases (such as alterations of pigmentation, bacterial or viral infections, mycoses, 
ulcers, lesions) or as a cosmetic formulation, being able to limit transdermal absorption to 
minimize systemic effects. 
3.9. Wound healing 
Due to the haemostatic, antimicrobial and healing properties of chitosan 36 and regeneration 
properties of 6-PG-Na+,20 ‘lyophilized hydrogel’ has been considered as dressing for wound 
healing. For this, the evolution of surgically created full thickness wounds at dorsum of Wistar 
rats has been evaluated. The animal model used is one of the most common for healing 
studies 37-39. The size of wounds created (3 cm in diameter) has been established based on 
previous studies 11 which show that when the area is smaller self-regeneration of the tissue 
dominates the process and the healing effect of the formulations tested is not appreciated. In 
any case, due to the self-regeneration the most important information of these results is 
obtained the first days after causing the injury. 
Fig. 9 shows the evolution of the wounds for 21 days in the animals treated with the hydrogel 
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Fig. 9. Evolution of full thickness wounds in the absence of treatment, and in the ones treated 




 and with the hydrogel M60-275. Images taken on the 
day 0 (skin excision), 7, 14 and 21 
 
Initial Day         7
th
 Day          14
th
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The percentage of wound closure, referring to the initial area, is collected in table 5 for each 
time studied.  
 
Day 
% wound closure 
Without treatment Chitosan 6-PG-Na+ Hydrogel 
7 26.10 ± 10.68 13.19 ± 10.76 10.68 ± 6.05 39.79 ± 11.21 
14 84.93 ± 5.05 80.84 ± 6.12 74.62 ± 2.01 82.34 ± 7.24 
21 96.17 ± 2.19 92.87 ± 2.34 90.26 ± 8.37 91.97 ± 3.24 
Table 5. Percentage of wound healing at 7, 14 and 21 days from skin excision in untreated rats 




 solution and hydrogel M60-275 
 
Observing the percentages of wound closure, the treatment of the groups with chitosan or 
with 6-PG-Na+ did not present any advantage over the control group. In the case of the group 
treated with the hydrogel, at 7 days the area of the wound is lower than the one of the group 
without treatment, with a percentage of wound closure of 39.79% compared to 26.10% of the 
group without treatment. At 14 and 21 days after surgical excision of the skin, both groups 
show a similar percentage of closure, due to the self-regeneration of the tissue. However, 
microscopic examination of skin samples at the end of the assay reveals that healing is more 
effective in the hydrogel treated group. Fig. 10.A shows the appearance of healthy skin, in 
which can be distinguished the dermis and the epidermis with the germinative, granular, 
spinous layer and stratum corneum. In Fig.10.B is shown the untreated wound, where 
granulation tissue and a large number of inflammatory infiltrate cells are distinguished; 
neovascularization is also observed, although the dermis and epidermis are not differentiated. 
This same observation is applied for the appearance of the wound treated with chitosan and 
with 6-PG-Na+ (Figure 10. C and D, respectively. The appearance of the wound treated with the 
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hydrogel is shown in Figure 10.E. In this case below the crust (that is separating from the 
tissue) the epidermis can be distinguished, with the germinative, granular and spinous layers, 
and in the dermis neovascularization can be observed. 
 
Fig. 10. Histology of skin of the different treatment groups, obtained at day 21. For comparison 
a full thickness healthy skin has been included (A). B: Wound not treated; C: Wound treated 
with chitosan dressing; D: Wound treated with 6-PG-Na; E: Wound treated with M60-275 
dressing. 
 
Overall, the hydrogel perform several actions that favour wound regeneration, as it creates a 
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and absorbs the exudate and secretions. The moist medium created by the hydrogel allows the 
debridement of necrotic tissue, helps tissue regeneration in the granulation stage and favours 
cell division and activity 40. Polymer network also serves as an extracellular matrix that 
facilitates reepithelization 11.  
In conclusion, the hydrogel M60-275 applied to full thickness wounds does not cause any 
damage to the tissues, but favours healing process, so it can be used as dressing for the 
application of therapeutic substances that promote healing. 
 
4. CONCLUSIONS 
This work has shown that the molecule 6-PG-Na+, soluble in water, is a promising new agent 
for chitosan crosslinking and, potentially, for other cationic polymers. The crosslinking reaction 
between this molecule and the polymer is based on ionic interaction between the anionic 
groups of the phosphoacid and cationic amino groups. Characterization studies have shown 
the interaction between chitosan and 6-PG-Na+, producing a reduction of thermal stability due 
to crosslinking and the formation of a polymer framework. It has been found that at pH ≤ 4.5 
hydrogel disintegrates within a few hours, probably due to loss of the negative charges of the 
crosslinker molecule. However, at pH values near neutrality the hydrogel maintains its 
integrity. The lower the crosslinking percentage, the higher the swelling is. These results agree 
with those obtained in release studies because the lower the pH and the lower the crosslinking 
percentage, the faster the drug release is. At pH 7.5 the hydrogel M6P-275 has released 90% of 
the drug within 7 hours. The release profiles follow a first order kinetics.  
It has been also shown that the proposed system is non-toxic in Caco-2 cells and its application 
does not produce skin irritation. In addition, it has been found that the extensibility properties 
of the rehydrated formulation are suitable for the cutaneous administration. Its application 
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over the skin creates a polymeric film like a patch with good adhesiveness properties. This 
polymer film allows the application of active substances topically, limiting its systemic action.  
The lyophilization of the formulation would allow product preservation until its application, 
keeping stable the hydrogel and the active substance contained therein. This lyophilised 
formulation can be applied as wound dressing, without previous rehydration, over full 
thickness wounds. With this mode of use it has been shown, at the microscopic level, that the 
hydrogel improves healing and regeneration of injured skin. Thus it can be used as wound 
dressing for wound healing, either alone or, preferably, as a drug application system for 
substances that promote healing. Moreover, the system can be useful to administrate 
different drugs on the skin or mucous membranes in order to obtain controlled release 
profiles. 
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